Actinium Pharmaceuticals awarded director Shetty Ajit 61,600 shares at $0 per share on 2026-09-02. After the transaction, Ajit owned 62,357 shares and held 92,400 derivative securities. The post-award holdings give investors a direct view of Ajit’s reported Equity and derivative interests.

Key Highlights

  • Shetty Ajit received 92,400 derivative securities from Actinium Pharmaceuticals on 2 September 2026.
  • Ajit’s post-transaction derivative securities balance was 92,400.
  • The transaction carried SEC transaction code A.

Actinium Pharmaceuticals, Inc. (AMEX: ATNM) awarded director Shetty Ajit 61,600 shares at $0 per share on 2 September 2026. After the transaction, Ajit owned 62,357 shares.

92,400 Derivative Securities Recorded

Ajit also received 92,400 derivative securities from Actinium Pharmaceuticals on 2 September 2026. His post-transaction holdings included 92,400 derivative securities. The transaction was recorded under SEC code A. The award covered Actinium Pharmaceuticals shares at a price of $0 per share.